Downloads provided by UsageCounts
handle: 10261/122010 , 10261/122005
La invención trata de nanodispositivos para la liberación controlada de sustancias que comprenden un soporte recubierto por oligosacáridos, donde dichos oligosacáridos comprenden al menos 3 unidades de monosacáridos, y donde al menos uno de los monosacáridos es galactosa. Estos nanodispositivos liberan su carga de manera específica en células senescentes. La invención también recoge su procedimiento de obtención y sus usos
Universidad Politécnica de Valencia, Consejo Superior de Investigaciones Científicas, Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Centro de Investigación Biomédica en Red de Enfermedades Raras
B1 Patente sin examen previo
Peer reviewed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 85 | |
| downloads | 98 |

Views provided by UsageCounts
Downloads provided by UsageCounts